Fact Check: Her term ends June 20.

Fact Check: Her term ends June 20.

Published June 13, 2025
VERDICT
False

# Fact Check: "Her term ends June 20." ## What We Know The claim that "her term ends June 20" refers to Dr. Theresa Tam, Canada's Chief Public Health...

Fact Check: "Her term ends June 20."

What We Know

The claim that "her term ends June 20" refers to Dr. Theresa Tam, Canada's Chief Public Health Officer. According to multiple sources, including Burnaby Now and The Star, Dr. Tam stated in a recent interview that her term indeed ends on June 20. However, it is important to clarify that this date is specifically the deadline for her graduation application, not the end of her official term in office. The academic calendar from the University of Maryland indicates that the term actually ends on July 25, 2025, with June 20 being the graduation application deadline (University of Maryland).

Analysis

While the statement about Dr. Tam's term ending on June 20 is accurate in the context of the graduation application deadline, it is misleading when taken out of context. The sources that report her statement do not clarify that June 20 is not the end of her official duties as Chief Public Health Officer. Instead, her term in this role is ongoing and will not conclude until a later date, as indicated by the academic calendar.

The reliability of the sources reporting on Dr. Tam's statement is generally high, as they are established news outlets. However, the lack of context regarding the nature of the June 20 date leads to potential misinterpretation of the claim. The academic calendar from the University of Maryland provides a clear timeline that contradicts the implication that her term ends on June 20 (University of Maryland).

Conclusion

Verdict: False
The claim that "her term ends June 20" is misleading. While June 20 is a significant date related to graduation applications, it does not represent the end of Dr. Tam's term as Chief Public Health Officer. Her official duties will continue beyond this date, with the academic calendar indicating that the term actually ends on July 25, 2025.

Sources

  1. Academic Calendar - Office of the Registrar
  2. Academic Calendar - UNIVERSITY OF MICHIGAN
  3. 她 Her (2013) - 豆瓣电影
  4. Canada's top doctor Theresa Tam leaving position when ...
  5. 如何评价 2013 年电影《Her》? - 知乎
  6. Canada's top doctor Theresa Tam leaving position when ...
  7. 消失的爱人 Gone Girl (2014) - 豆瓣电影
  8. Chief Public Health Officer Dr. Theresa Tam leaving position

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: trump said Sanctuary cities are protecting criminals, not communities. Nearly 70% of criminals arrested in Washington went unprosecuted in 2022, that ends here.
Partially True
🎯 Similar

Fact Check: trump said Sanctuary cities are protecting criminals, not communities. Nearly 70% of criminals arrested in Washington went unprosecuted in 2022, that ends here.

Detailed fact-check analysis of: trump said Sanctuary cities are protecting criminals, not communities. Nearly 70% of criminals arrested in Washington went unprosecuted in 2022, that ends here.

Aug 18, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Her term ends June 20. | TruthOrFake Blog